Medical Device registration in China, Classification, Licensing, CFDA

Freyr offers Medical Device registration in China, classification, labeling, licensing, Clinical trial support, local agent representation, Dossier compilation, Linguistic Translation Support for Submission Documents to comply with China Food and Drug Administration’s (CFDA) & Centre for Medical Device Evaluation (CMDE)

– Freyr Webpage Link –

Medical Device Registration in China

Freyr Expertise

  • Regulatory Assistance for Registration
  • Medical Device Classification
  • Clinical Trial Support
  • Chinese Local Agent Representation
  • Testing Data and Dossier/Documents Compilation
  • Assistance for Listing Product Technical Specifications
  • Linguistic Translation Support for all Submission Documents
  • Post-Market Surveillance

Comments

Post a Comment

Popular posts from this blog

Medical Device Regulation Report, Morocco, Registration

This report provides information on regulations imposed on medical device in Morocco for product registration, import permit, validity & renewal process, variations filing, legal representative and labeling. Summary Product definition and governing regulations; Information on medical device registration; Explains the process of registration through flowcharts; Precise information on health authority fees & timelines for registration; Additional information on the validity of registration, renewal process and variation filing Presents the regulations applicable on labeling; and Describes the information on import regulations, and the requirement of a legal representative. Check out more details at  Medical Device Regulation Report, Morocco, Registration
Read more

Best eCTD Software Tool for global eCTD Submissions

Freyr SUBMIT Pro is one of the best eCTD software tool which helps Life science companies in various regulatory submissions to global health Authorities. Smarter the electronic Common Technical Document (eCTD) publishing Software, smoother will be the eCTD submission process. It all depends on how effective an eCTD software is to create, validate, track, publish, view, and manage the entire documentation lifecycle inclusive of complete clinical/pre-clinical research data. In addition, the functionality to be considered is the eCTD Software’s adoptability to region-specific submission formats under strict eCTD guidelines and compliance timelines. It might be time consuming at times to manage or convert the existing data into different  region-specific eCTD templates / submission formats  like: Investigational New Drugs (INDs) New Drug Applications (NDAs) Abbreviated New Drug Applications (ANDAs) Marketing Authorization Applications (MAA) New Drug Submission (NDS) A...
Read more